Showing 23,074 news articles about PEP

Filters Content type: Editors' picks Topic: PEP

Post-exposure prophylaxis involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV. It may be used by healthcare workers (occupational PEP) or after sex (post-exposure prophylaxis after sexual exposure, PEPSE, also known as non-occupational PEP or nPEP).

New & experimental hepatitis C treatment

Like Gilead, Achillion Should Trade Up On Bad News For Bristol-Myers, Idenix

Editor's pick
Reuters
2 August 2012
New & experimental hepatitis C treatment

Bristol-Myers Suspends Hepatitis C Drug Clinical Trial - Bloomberg

Editor's pick
Google Alerts - Hepatitis
2 August 2012
Hepatitis C transmission & prevention

Did 'Serial Infector' Spread Hep. C to Thousands?

Editor's pick
Reuters
1 August 2012
New & experimental hepatitis C treatment

Gilead Begins Single Pill Hepatitis C Study for 2014 Approval

Editor's pick
Businessweek
29 July 2012
New & experimental hepatitis C treatment

Vitamin B12 supplements may help treat hepatitis C

Editor's pick
Eurekalert
18 July 2012
Activism & civil society

Advocacy group forms for hepatitis C patients

Editor's pick
WCVB Boston
28 June 2012
Hepatitis C treatment

Hepatitis C treatment under threat from welfare reform

Editor's pick
Herald Scotland
24 June 2012
Hepatitis C transmission & prevention

Feds join hepatitis C outbreak investigation in NH

Editor's pick
Boston.com
20 June 2012
Hepatitis & HIV

Hep C payouts reach €1bn with more to come

Editor's pick
Irish Independent
19 June 2012
Hepatitis C treatment

Pakistan: Hepatitis C treatment crisis in Punjab

Editor's pick
Pakistan Daily Times
9 June 2012
New & experimental hepatitis C treatment

Bristol urges combo study with Gilead hepatitis drug

Editor's pick
Reuters
31 May 2012
New & experimental hepatitis C treatment

Hepatitis C 'switch' offers target for new drug research

Editor's pick
Science Codex
31 May 2012
Hepatitis C treatment

FDA says Vertex promotional material overstates benefits of hepatitis C drug

Editor's pick
Boston Globe
31 May 2012
New & experimental hepatitis C treatment

GSK seeks to expand low-platelet drug Promacta to hepatitis C patients

Editor's pick
MedCity News
31 May 2012
Pharmaceutical industry

How CDC's hep.-C testing advice is already benefiting drugmakers

Editor's pick
Medical Marketing and Media
23 May 2012
Hepatitis C symptoms & diagnosis

CDC recommends hepatitis C tests for all baby boomers

Editor's pick
Washington Post
20 May 2012
New & experimental hepatitis C treatment

Achillion's hepatitis C drug gets FDA fast track

Editor's pick
Reuters
16 May 2012
New & experimental hepatitis C treatment

Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy

Editor's pick
MarketWatch (press release)
8 May 2012
Hepatitis C transmission & prevention

Hepatitis C a latent legacy of baby boomers' youth

Editor's pick
Los Angeles Times
2 May 2012
Pharmaceutical industry

Gilead Sciences 1Q profit down on Pharmasset costs

Editor's pick
CBS News
27 April 2012
Hepatitis & HIV

Conference Highlights: EASL Monothematic Conference: HIV and the Liver

Editor's pick
European Association for the Study of the Liver (EASL)
14 March 2013
Hepatitis C treatment

London Mayor welcomes news of prestigious 2014 medical conference

Editor's pick
European Association for the Study of the Liver (EASL)
14 August 2012
Sexually transmitted infections tests & treatment

The recent trend towards multi-resistant gonorrhoea in coastal China

Editor's pick
BMJ Group blogs
29 March 2018
Global health targets

Empirical evidence that achievement of UNAIDS 90-90-90 can deliver promised HIV elimination?

Editor's pick
BMJ Group blogs
19 December 2017